Determine whether tumour‐derived CEACAM1 (a cell‐membrane receptor expressed in malignant cells) inhibits NK cell cytotoxicity and whether blockade of CEACAM1 restores antitumor immunity. Here, CEACAM1 is linked to neoplasm.